propylparaben has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adhikari, S; Driver, EM; Halden, RU; Johnston, B; Kumar, R; Perleberg, TD; Yanez, A | 1 |
| Elkhatib, WF; Elleboudy, NS; Hassouna, NA; Singab, RA; Yassein, MA | 1 |
2 other study(ies) available for propylparaben and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Mass trends of parabens, triclocarban and triclosan in Arizona wastewater collected after the 2017 FDA ban on antimicrobials and during the COVID-19 pandemic.
Topics: Anti-Infective Agents; Arizona; Carbanilides; Chromatography, Liquid; COVID-19; Humans; Longitudinal Studies; Pandemics; Parabens; Tandem Mass Spectrometry; Triclosan; United States; United States Food and Drug Administration; Wastewater | 2022 |
Improvement of caffeic acid biotransformation into para-hydroxybenzoic acid by Candida albicans CI-24 via gamma irradiation and model-based optimization.
Topics: Biotransformation; Caffeic Acids; Candida albicans; COVID-19; Fermentation; Parabens; SARS-CoV-2 | 2022 |